Your browser doesn't support javascript.
loading
Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection.
Peraro, Leila; Bourne, Christopher M; Dacek, Megan M; Akalin, Enver; Park, Jae H; Smith, Eric L; Scheinberg, David A.
Affiliation
  • Peraro L; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Bourne CM; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA.
  • Dacek MM; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA.
  • Akalin E; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA.
  • Park JH; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Smith EL; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Scheinberg DA; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: scheinbd@mskcc.org.
Mol Ther ; 29(12): 3398-3409, 2021 12 01.
Article in En | MEDLINE | ID: mdl-34217891
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Mol Ther Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Mol Ther Year: 2021 Document type: Article